State Of Wisconsin Investment Board Omeros Corp Transaction History

State Of Wisconsin Investment Board

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.92 - $6.28 $11,516 - $37,667	-5,998 Reduced 7.45%	74,502 $205,000
Q1 2022 May 13, 2022	BUY	$5.07 - $7.2 $408,135 - $579,600	80,500 New	80,500 $484,000
Q4 2021 Feb 11, 2022	SELL	$5.67 - $8.54 $469,476 - $707,111	-82,800 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$10.14 - $15.19 $14,196 - $21,266	-1,400 Reduced 1.66%	82,800 $1.18 Million
Q2 2020 Aug 12, 2020	BUY	$12.21 - $16.99 $137,973 - $191,986	11,300 Added 15.5%	84,200 $1.24 Million
Q1 2020 May 06, 2020	BUY	$9.03 - $19.72 $49,665 - $108,460	5,500 Added 8.16%	72,900 $975,000
Q2 2019 Aug 14, 2019	BUY	$15.0 - $19.62 $90,000 - $117,720	6,000 Added 9.77%	67,400 $1.06 Million
Q1 2019 May 13, 2019	BUY	$11.65 - $17.72 $164,265 - $249,851	14,100 Added 29.81%	61,400 $1.07 Million
Q4 2018 Feb 11, 2019	BUY	$10.72 - $16.73 $6,432 - $10,038	600 Added 1.28%	47,300 $527,000
Q2 2018 Aug 03, 2018	BUY	$10.79 - $24.44 $22,659 - $51,324	2,100 Added 4.71%	46,700 $847,000
Q4 2017 Feb 08, 2018	BUY	$13.26 - $22.86 $286,416 - $493,776	21,600 Added 93.91%	44,600 $867,000
Q3 2017 Nov 01, 2017	BUY	$19.76 - $24.9 $454,480 - $572,700	23,000	23,000 $497,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $762M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.